Holen Sie sich die Stockscreener-App
4.74
0.85%
0.04
Handel nachbörslich:
4.90
0.16
+3.38%
Schlusskurs vom Vortag:
$4.70
Offen:
$5.125
24-Stunden-Volumen:
19,390
Relative Volume:
0.48
Marktkapitalisierung:
$7.05M
Einnahmen:
$27.40M
Nettoeinkommen (Verlust:
$-17.12M
KGV:
-0.0443
EPS:
-106.8896
Netto-Cashflow:
$-24.99M
1W Leistung:
-0.21%
1M Leistung:
-7.06%
6M Leistung:
-17.57%
1J Leistung:
-74.18%
1-Tages-Spanne:
$4.50
$5.4966
1-Wochen-Bereich:
$4.34
$5.4966
52-Wochen-Spanne:
$2.5211
$38.52
Dna X Inc Stock (SONM) Company Profile
Firmenname
Dna X Inc
Sektor
Branche
Telefon
650-378-8100
Adresse
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, FTNT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
4.74 | 7.05M | 27.40M | -17.12M | -24.99M | -106.89 |
MSFT
Microsoft Corp
|
390.74 | 2.90T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
184.13 | 529.57B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
127.99 | 306.83B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
682.80 | 173.82B | 5.09B | -24.89M | 1.43B | -0.1885 |
FTNT
Fortinet Inc
|
146.30 | 107.19B | 7.11B | 1.95B | 2.44B | 2.5883 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-10-31 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-07-18 | Eingeleitet | B. Riley FBR | Buy |
| 2019-07-09 | Hochstufung | National Securities | Neutral → Buy |
| 2019-06-10 | Eingeleitet | National Securities | Neutral |
| 2019-06-04 | Eingeleitet | Lake Street | Buy |
| 2019-06-04 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Dna X Inc Aktie (SONM) Neueste Nachrichten
[EFFECT] DNA X, Inc. SEC Filing - Stock Titan
DNA X (SONM) deregisters 350M common shares tied to Chardan resale - Stock Titan
11 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session - Benzinga
DNA X, Inc. (formerly Sonim Technologies) Terminates Material Definitive Agreement – SEC Form 8-K Filing June 2026 - Minichart
Sonim Technologies Ends Major Equity Purchase Agreement - TipRanks
12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga
DNA X Ends $500 Million ChEF Equity Facility and Related Registration Rights With Chardan - TradingView
DNA X (NASDAQ: SONM) terminates $500M Chardan equity facility - Stock Titan
Natera Inc stock (US6323071042): insider sales and new oncology board appointments in focus - AD HOC NEWS
DNA X: Q1 Earnings Snapshot - AOL.com
Lotus Technology Inc. Unveils Eletre X: A Revolutionary Hybrid SUV Offering 1,200+ km Range and Supercar Performance Starting at €96,990 - Quiver Quantitative
12 Information Technology Stocks Moving In Tuesday's Intraday Session - Benzinga
How DNA's Double Helix Structure Was Discovered - Britannica
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights - Business Wire
SONM Q3 2024 Earnings: EPS Surprises to the Upside with 22.76% Beat; Stock Rises 4%Preliminary Results - The Legal Advocate
SONM Q3 2024 Earnings: EPS Surprises Higher by 22.76%, Stock Rises Over 4%One-Time Gain Impact - The Legal Advocate
SONM Q3 2024 Earnings: EPS Beats Estimates by 22.76% Amid Cost DisciplineRetail Earnings Report - thelegaladvocate.com
DNA X Inc. (SONM) Shares Rise Nearly 6% as Buyer Interest Surges Near Key SupportGrowth ETF - newsline.com
S&P 500 Edges Higher as Healthcare and Tech Rally Outweigh Utility DeclinePPI Inflation Report - thelegaladvocate.com
DNA X Inc. (SONM) Rallies 4.18% as Momentum Builds Toward Key ResistanceEntry Point Alerts - The Legal Advocate
DNA X, Inc. Enters Securities Purchase Agreement with DNA Holdings Venture, Inc. and Issues Convertible Note – Key Details and Terms - Minichart
DNA X Stock Looks at Nasdaq Deadline After Latest Financing - Bez Kabli
Sonim Technologies Faces Nasdaq Delisting After New Financing - TipRanks
DNA X Received Notice of Delisting - TradingView
CIA Accused of Searching Ancestry DNA for "Alien Genetics" - hypefresh.com
Why people are losing it over Ferrari’s first all-electric car - Fast Company
SONM - Finviz
DNA X, Inc. announced that it has received $3.052788 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
DNA X Inc. (SONM) Q3 2024 Earnings: EPS Beats Estimates, Stock Surges 13.71%Community Hot Stocks - Newser
DNA X Inc. (SONM) Surges 13% as Buyer Demand Tests Key Resistance at $4.68Institutional Grade Picks - Newser
Ginkgo Bioworks Holdings Inc (DNA): What’s the Future of Autonomous Lab? - Yahoo Finance Singapore
12 Information Technology Stocks Moving In Thursday's Intraday SessionAmplitech Group, Inc.Series A - Benzinga
DNA X, Inc. (SONM) Reports Q1 2026 Financial Results, Completes Mobile Business Sale, and Focuses on AI Crypto Trading Platform – Minichart - Minichart
DNA X, Inc. Reports First Quarter 2026 Financial Results - Scott Coop
DNA X, Inc. 1Q 2026: Revenue $0 Net income $6.34M, EPS $5.01— 10-Q Summary - TradingView
SONM: Q1 2026 net income surged to $6.3M on asset sale, but core crypto trading posted a $3.9M loss - TradingView
DNA X, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
DNA X (NASDAQ: SONM) exits handset business, leans on crypto platform and new funding - Stock Titan
SONM: Exited legacy business, posted strong net income, and pivoted to AI crypto trading platform - TradingView
DNA X (NASDAQ: SONM) exits phones, pivots to AI crypto trading - Stock Titan
FMAC Price Today: Future Money Acquisition Corporation Stock Price, Quote & Chart | MEXC - MEXC Exchange
AUC Price Today: ATIF Holdings Limited Stock Price, Quote & Chart | MEXC - MEXC
Stock Market News for May 20, 2026 - Stock Titan
DNA X, Inc. announced that it expects to receive $3.052788 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
Why Is DNA Brands, Inc. (DNAX) Stock Down Today? - Meyka
SONM Stock Price, Quote & Chart | DNA X INC (NASDAQ:SONM) - ChartMill
DNA X, Inc. Delays Quarterly Filing After Asset Sale - TipRanks
12 Information Technology Stocks Moving In Friday's After-Market Session - Benzinga
DNA X (SONM) delays Q1 2026 10-Q after Legacy Business sale; expects $3.6M loss - Stock Titan
Dna Brands Inc (OP: DNAX - The Chronicle-Journal
Finanzdaten der Dna X Inc-Aktie (SONM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
0.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):